![Figure 4. Effects of combining hLL1 and rituximab on proliferation of cell lines. Antiproliferative effects of the anti–B-cell mAbs given in combination were assessed by measuring the uptake of [3H]-thymidine in comparison with untreated control cells. Error bars represent SD. (A) Cell lines were incubated with hLL1(▪), rituximab (▦), or both mAbs (□) in the presence of GAH second antibody. (B) Cell lines were incubated with hLL1(▪), rituximab (▦), or both mAbs (□) without a cross-linking agent.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/104/12/10.1182_blood-2004-03-0890/5/zh80230469970004.jpeg?Expires=1764634325&Signature=RXv4Vn92lmedJBdtQIvcaEBkGh6g85GquJRZ4dR-Yj9UkJn~S6-dF6GxQ8ev6Jjhx3kznu9Sqs2EyP-ZGZs~jmfJVUwdbyEc5fUMAyUT8OvOkC6gfTOUstu0ERaLvySkp-54r5fwFiEyYs0M~rY9Qycha4ih6wmBkhxt58Q8~IZgXQq9XE05nncLkOceR5rasOk1RRbd4kpb4xtbi5o19LPPJt082EvrpjZHkwu5QgOvd6ssfMyWKRKpkxEIWcaMB5x9q3yim0ilLlxY0l42mYUK0NbeAyTPfp6Us2cBZb1quPg1E4dSvykjIrLadVgTObtX1-~8KA2vgR9nUP11Lw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Figure 4.
Effects of combining hLL1 and rituximab on proliferation of cell lines. Antiproliferative effects of the anti–B-cell mAbs given in combination were assessed by measuring the uptake of [3H]-thymidine in comparison with untreated control cells. Error bars represent SD. (A) Cell lines were incubated with hLL1(▪), rituximab (▦), or both mAbs (□) in the presence of GAH second antibody. (B) Cell lines were incubated with hLL1(▪), rituximab (▦), or both mAbs (□) without a cross-linking agent.
